The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
Frank M. Sacks, M.D., Marc A. Pfeffer, M.D., Ph.D., Lemuel A. Moye, M.D., Ph.D., Jean L. Rouleau, M.D., John D. Rutherford, M.D., Thomas G. Cole, Ph.D., Lisa Brown, M.P.H., J. Wayne Warnica, M.D., J. Malcolm O. Arnold, M.D., Chuan-Chuan Wun, Ph.D., Barry R. Davis, M.D., Ph.D., Eugene Braunwald, M.D., for The Cholesterol and, for Recurrent Events Trial Investigators
Background In patients with high cholesterol levels, loweringthe cholesterol level reduces the risk of coronary events, butthe effect of lowering cholesterol levels in the majority ofpatients with coronary disease, who have average levels, isless clear.
Methods In a double-blind trial lasting five years, we administeredeither 40 mg of pravastatin per day or placebo to 4159 patients(3583 men and 576 women) with myocardial infarction who hadplasma total cholesterol levels below 240 mg per deciliter (mean,209) and low-density lipoprotein (LDL) cholesterol levels of115 to 174 mg per deciliter (mean, 139). The primary end pointwas a fatal coronary event or a nonfatal myocardial infarction.
Results The frequency of the primary end point was 10.2 percentin the pravastatin group and 13.2 percent in the placebo group,an absolute difference of 3 percentage points and a 24 percentreduction in risk (95 percent confidence interval, 9 to 36 percent;P = 0.003). Coronary bypass surgery was needed in 7.5 percentof the patients in the pravastatin group and 10 percent of thosein the placebo group, a 26 percent reduction (P = 0.005), andcoronary angioplasty was needed in 8.3 percent of the pravastatingroup and 10.5 percent of the placebo group, a 23 percent reduction(P = 0.01). The frequency of stroke was reduced by 31 percent(P = 0.03). There were no significant differences in overallmortality or mortality from noncardiovascular causes. Pravastatinlowered the rate of coronary events more among women than amongmen. The reduction in coronary events was also greater in patientswith higher pretreatment levels of LDL cholesterol.
Conclusions These results demonstrate that the benefit of cholesterol-loweringtherapy extends to the majority of patients with coronary diseasewho have average cholesterol levels.
Source Information
From the Departments of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (F.M.S., M.A.P., L.B., E.B.); the University of Texas School of Public Health, Houston (L.A.M., C.-C.W., B.R.D.); the University of Sherbrooke, Sherbrooke, Que., Canada (J.L.R.); the University of Texas Southwestern Medical Center, Dallas (J.D.R.); Washington University, St. Louis (T.G.C.); Foothills Hospital, Calgary, Alta., Canada (J.W.W.); and Victoria Hospital, London, Ont., Canada (J.M.O.A.). Other contributing authors were Pierre Theroux, M.D., Montreal Heart Institute, Montreal; David T. Nash, M.D., State University of New York Health Sciences Center, Syracuse; and C. Morton Hawkins, D.Sc., University of Texas School of Public Health, Houston.
Address reprint requests to Dr. Sacks at Brigham and Women's Hospital, 75 Francis St., Boston, MA 02115.
Gupta, M., Braga, M. F. B., Teoh, H., Tsigoulis, M., Verma, S.
(2009). Statin Effects on LDL and HDL Cholesterol in South Asian and White Populations. J Clin Pharmacol
49: 831-837
[Abstract][Full Text]
Meaney, A., Ceballos, G., Asbun, J., Solache, G., Mendoza, E., Vela, A., Meaney, E.
(2009). The Vytorin on Carotid Intima-Media Thickness and Overall Arterial Rigidity (VYCTOR) Study. J Clin Pharmacol
49: 838-847
[Abstract][Full Text]
Imamura, M, Dohi, M
(2009). Authors' reply. Thorax
64: 549-549
[Full Text]
Meijer, P., Oyen, W. J.G., Dekker, D., van den Broek, P. H.H., Wouters, C. W., Boerman, O. C., Scheffer, G. J., Smits, P., Rongen, G. A.
(2009). Rosuvastatin Increases Extracellular Adenosine Formation in Humans In Vivo: A New Perspective on Cardiovascular Protection. Arterioscler. Thromb. Vasc. Bio.
29: 963-968
[Abstract][Full Text]
Ashikaga, H., Marine, J. E
(2009). Prevention of atrial fibrillation: another good reason to recommend statins to women?. Heart
95: 693-694
[Full Text]
Tonkin, A M, Forbes, A, Haas, S J
(2009). The evidence on trial: cholesterol lowering and cancer. Heart Asia
2009: 6-10
[Full Text]
Alexander, K. P., Blazing, M. A., Rosenson, R. S., Hazard, E., Aronow, W. S., Smith, S. C. Jr, Ohman, E. M.
(2009). Management of Hyperlipidemia in Older Adults. J CARDIOVASC PHARMACOL THER
14: 49-58
[Abstract]
Xu, J., Liu, X., Chen, J., Zacharek, A., Cui, X., Savant-Bhonsale, S., Liu, Z., Chopp, M.
(2009). Simvastatin enhances bone marrow stromal cell differentiation into endothelial cells via notch signaling pathway. Am. J. Physiol. Cell Physiol.
296: C535-C543
[Abstract][Full Text]
Sassano, A., Lo Iacono, M., Antico, G., Jordan, A., Uddin, S., Calogero, R. A., Platanias, L. C.
(2009). Regulation of leukemic cell differentiation and retinoid-induced gene expression by statins. Molecular Cancer Therapeutics
8: 615-625
[Abstract][Full Text]
Shalev, V., Chodick, G., Silber, H., Kokia, E., Jan, J., Heymann, A. D.
(2009). Continuation of Statin Treatment and All-Cause Mortality: A Population-Based Cohort Study. Arch Intern Med
169: 260-268
[Abstract][Full Text]
Monzack, E. L., Gu, X., Masters, K. S.
(2009). Efficacy of Simvastatin Treatment of Valvular Interstitial Cells Varies With the Extracellular Environment. Arterioscler. Thromb. Vasc. Bio.
29: 246-253
[Abstract][Full Text]
Kushiro, T., Mizuno, K., Nakaya, N., Ohashi, Y., Tajima, N., Teramoto, T., Uchiyama, S., Nakamura, H., for the Management of Elevated Cholesterol in the,
(2009). Pravastatin for Cardiovascular Event Primary Prevention in Patients With Mild-to-Moderate Hypertension in the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study. Hypertension
53: 135-141
[Abstract][Full Text]
Robinson, J. G., Wang, S., Smith, B. J., Jacobson, T. A.
(2009). Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk.. J Am Coll Cardiol
53: 316-322
[Abstract][Full Text]
Kerr, A J, Broad, J, Wells, S, Riddell, T, Jackson, R
(2009). Should the first priority in cardiovascular risk management be those with prior cardiovascular disease?. Heart
95: 125-129
[Abstract][Full Text]
Liu, P.-Y., Liu, Y.-W., Lin, L.-J., Chen, J.-H., Liao, J. K.
(2009). Evidence for Statin Pleiotropy in Humans: Differential Effects of Statins and Ezetimibe on Rho-Associated Coiled-Coil Containing Protein Kinase Activity, Endothelial Function, and Inflammation. Circulation
119: 131-138
[Abstract][Full Text]
Tabata, M., Khalpey, Z., Cohn, L. H., Chen, F. Y., Bolman, R. M. III, Rawn, J. D.
(2008). Effect of preoperative statins in patients without coronary artery disease who undergo cardiac surgery.. J. Thorac. Cardiovasc. Surg.
136: 1510-1513
[Abstract][Full Text]
Jukema, J W., Bergheanu, S. C
(2008). Statins: established indications and controversial subgroups. Heart
94: 1656-1662
[Full Text]
Bhindi, R., Ormerod, O., Newton, J., Banning, A.P., Testa, L.
(2008). Interaction between statins and clopidogrel: is there anything clinically relevant?. QJM
101: 915-925
[Abstract][Full Text]
Jacobson, T. A., Wertz, D. A., Hoy, T., Kuznik, A., Grochulski, D., Cziraky, M.
(2008). Comparison of Cardiovascular Event Rates in Patients Without Cardiovascular Disease in Whom Atorvastatin or Simvastatin Was Newly Initiated. Mayo Clin Proc.
83: 1316-1325
[Abstract][Full Text]
Schmeer, C., Gamez, A., Tausch, S., Witte, O. W., Isenmann, S.
(2008). Statins Modulate Heat Shock Protein Expression and Enhance Retinal Ganglion Cell Survival after Transient Retinal Ischemia/Reperfusion In Vivo. IOVS
49: 4971-4981
[Abstract][Full Text]
Young, M. J., McCardle, J. E., Randall, L. E., Barclay, J. I.
(2008). Improved Survival of Diabetic Foot Ulcer Patients 1995-2008: Possible impact of aggressive cardiovascular risk management. Diabetes Care
31: 2143-2147
[Abstract][Full Text]
Wiesbauer, F., Heinze, G., Mitterbauer, C., Harnoncourt, F., Horl, W. H., Oberbauer, R.
(2008). Statin Use Is Associated with Prolonged Survival of Renal Transplant Recipients. J. Am. Soc. Nephrol.
19: 2211-2218
[Abstract][Full Text]
Prakash, C., Chen, W., Rossulek, M., Johnson, K., Zhang, C., O'Connell, T., Potchoiba, M., Dalvie, D.
(2008). Metabolism, Pharmacokinetics, and Excretion of a Cholesteryl Ester Transfer Protein Inhibitor, Torcetrapib, in Rats, Monkeys, and Mice: Characterization of Unusual and Novel Metabolites by High-Resolution Liquid Chromatography-Tandem Mass Spectrometry and 1H Nuclear Magnetic Resonance. Drug Metab. Dispos.
36: 2064-2079
[Abstract][Full Text]
Rosenzweig, J. L., Ferrannini, E., Grundy, S. M., Haffner, S. M., Heine, R. J., Horton, E. S., Kawamori, R.
(2008). Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab.
93: 3671-3689
[Abstract][Full Text]
Alsheikh-Ali, A. A., Trikalinos, T. A., Kent, D. M., Karas, R. H.
(2008). Statins, Low-Density Lipoprotein Cholesterol, and Risk of Cancer. J Am Coll Cardiol
52: 1141-1147
[Abstract][Full Text]
Peto, R., Emberson, J., Landray, M., Baigent, C., Collins, R., Clare, R., Califf, R.
(2008). Analyses of Cancer Data from Three Ezetimibe Trials. NEJM
359: 1357-1366
[Abstract][Full Text]
Lopez, J., Mendoza, R., Cleva Villanueva, G., Martinez, G., Castillo, E. F., Castillo, C.
(2008). Participation of K+ Channels in the Endothelium-Dependent and Endothelium-Independent Components of the Relaxant Effect of Rosuvastatin in Rat Aortic Rings. J CARDIOVASC PHARMACOL THER
13: 207-213
[Abstract]
Wei, L, Lang, C C, Sullivan, F M, Boyle, P, Wang, J, Pringle, S D, MacDonald, T M
(2008). Impact on mortality following first acute myocardial infarction of distance between home and hospital: cohort study. Heart
94: 1141-1146
[Abstract][Full Text]
Steinberg, D., Glass, C. K., Witztum, J. L.
(2008). Evidence Mandating Earlier and More Aggressive Treatment of Hypercholesterolemia. Circulation
118: 672-677
[Full Text]
Divchev, D., Grothusen, C., Luchtefeld, M., Thoenes, M., Onono, F., Koch, R., Drexler, H., Schieffer, B.
(2008). Impact of a combined treatment of angiotensin II type 1 receptor blockade and 3-hydroxy-3-methyl-glutaryl-CoA-reductase inhibition on secretory phospholipase A2-type IIA and low density lipoprotein oxidation in patients with coronary artery disease. Eur Heart J
29: 1956-1965
[Abstract][Full Text]
Goldman, R. E., Sanchez-Hernandez, M., Ross-Degnan, D., Piette, J. D., Trinacty, C. M., Simon, S. R.
(2008). Developing an automated speech-recognition telephone diabetes intervention. Int J Qual Health Care
20: 264-270
[Abstract][Full Text]
Nakagawa, T.
(2008). Argatroban caused severe hypercholesterolaemia in a chronic haemodialysis patient with heparin-induced thrombocytopenia: an unreported adverse effect?. NDT Plus
1: 277-277
[Full Text]
Kataoka, H.
(2008). Response to Letter by Paraskevas. Stroke
39: e135-e135
[Full Text]
Filippatos, T. D., Mikhailidis, D. P.
(2008). Statins and Heart Failure. ANGIOLOGY
59: 58S-61S
[Abstract]
Woodard, J., Sassano, A., Hay, N., Platanias, L. C.
(2008). Statin-Dependent Suppression of the Akt/Mammalian Target of Rapamycin Signaling Cascade and Programmed Cell Death 4 Up-Regulation in Renal Cell Carcinoma. Clin. Cancer Res.
14: 4640-4649
[Abstract][Full Text]
Caplan, L. R.
(2008). A 70-Year-Old Man With a Transient Ischemic Attack: Review of Internal Carotid Artery Stenosis. JAMA
300: 81-90
[Abstract][Full Text]
Ravnskov, U.
(2008). Re: The Association Between Statins and Cancer Incidence in a Veterans Population. JNCI J Natl Cancer Inst
100: 972-973
[Full Text]
Zhou, M.-S., Schuman, I. H., Jaimes, E. A., Raij, L.
(2008). Renoprotection by statins is linked to a decrease in renal oxidative stress, TGF-{beta}, and fibronectin with concomitant increase in nitric oxide bioavailability. Am. J. Physiol. Renal Physiol.
295: F53-F59
[Abstract][Full Text]
Reaume, K. T, Erickson, S. R, Dorsch, M. P, Dunham, N. L., Hiniker, S. M, Prabhakar, N., Kline-Rogers, E. M, Eagle, K. A
(2008). Effects of Cerivastatin Withdrawal on Statin Persistence. The Annals of Pharmacotherapy
42: 956-961
[Abstract][Full Text]
Fujii, T., Onimaru, M., Yonemitsu, Y., Kuwano, H., Sueishi, K.
(2008). Statins restore ischemic limb blood flow in diabetic microangiopathy via eNOS/NO upregulation but not via PDGF-BB expression. Am. J. Physiol. Heart Circ. Physiol.
294: H2785-H2791
[Abstract][Full Text]
Caymaz, H. O., Yuksel, G.
(2008). Fate of Incidental, Asymptomatic Lesions Discovered During Percutaneous Coronary Intervention. ANGIOLOGY
59: 193-197
[Abstract]
Brunzell, J. D., Davidson, M., Furberg, C. D., Goldberg, R. B., Howard, B. V., Stein, J. H., Witztum, J. L.
(2008). Lipoprotein Management in Patients With Cardiometabolic Risk: Consensus Conference Report From the American Diabetes Association and the American College of Cardiology Foundation. J Am Coll Cardiol
51: 1512-1524
[Full Text]
Golomb, B. A., Dimsdale, J. E., White, H. L., Ritchie, J. B., Criqui, M. H.
(2008). Reduction in Blood Pressure With Statins: Results From the UCSD Statin Study, a Randomized Trial. Arch Intern Med
168: 721-727
[Abstract][Full Text]
Howard, B. V., Roman, M. J., Devereux, R. B., Fleg, J. L., Galloway, J. M., Henderson, J. A., Howard, Wm. J., Lee, E. T., Mete, M., Poolaw, B., Ratner, R. E., Russell, M., Silverman, A., Stylianou, M., Umans, J. G., Wang, W., Weir, M. R., Weissman, N. J., Wilson, C., Yeh, F., Zhu, J.
(2008). Effect of Lower Targets for Blood Pressure and LDL Cholesterol on Atherosclerosis in Diabetes: The SANDS Randomized Trial. JAMA
299: 1678-1689
[Abstract][Full Text]
Albert, N. M., Lewis, C.
(2008). Recognizing and Managing Asymptomatic Left Ventricular Dysfunction: After Myocardial Infarction. Crit Care Nurse
28: 20-37
[Full Text]
Nusca, A., Melfi, R., Di Sciascio, G.
(2008). Review: Percutaneous coronary interventions and statins therapy. Ther Adv Cardiovasc Dis
2: 101-107
[Abstract]
Setoguchi, S., Glynn, R. J., Avorn, J., Mittleman, M. A., Levin, R., Winkelmayer, W. C.
(2008). Improvements in Long-Term Mortality After Myocardial Infarction and Increased Use of Cardiovascular Drugs After Discharge: A 10-Year Trend Analysis. J Am Coll Cardiol
51: 1247-1254
[Abstract][Full Text]
Brunzell, J. D., Davidson, M., Furberg, C. D., Goldberg, R. B., Howard, B. V., Stein, J. H., Witztum, J. L.
(2008). Lipoprotein Management in Patients With Cardiometabolic Risk: Consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care
31: 811-822
[Full Text]
Griel, A. E., Cao, Y., Bagshaw, D. D., Cifelli, A. M., Holub, B., Kris-Etherton, P. M.
(2008). A Macadamia Nut-Rich Diet Reduces Total and LDL-Cholesterol in Mildly Hypercholesterolemic Men and Women. J. Nutr.
138: 761-767
[Abstract][Full Text]
Wenger, N K, Lewis, S J, Welty, F K, Herrington, D M, Bittner, V, on behalf of the TNT Steering Committee and Invest,
(2008). Beneficial effects of aggressive low-density lipoprotein cholesterol lowering in women with stable coronary heart disease in the Treating to New Targets (TNT) study. Heart
94: 434-439
[Abstract][Full Text]
Lewis, E. F., Velazquez, E. J., Solomon, S. D., Hellkamp, A. S., McMurray, J. J.V., Mathias, J., Rouleau, J.-L., Maggioni, A. P., Swedberg, K., Kober, L., White, H., Dalby, A. J., Francis, G. S., Zannad, F., Califf, R. M., Pfeffer, M. A.
(2008). Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study. Eur Heart J
29: 748-756
[Abstract][Full Text]
Sabatine, M. S., Ploughman, L., Simonsen, K. L., Iakoubova, O. A., Kirchgessner, T. G., Ranade, K., Tsuchihashi, Z., Zerba, K. E., Long, D. U., Tong, C. H., Packard, C. J., Pfeffer, M. A., Devlin, J. J., Shepherd, J., Campos, H., Sacks, F. M., Braunwald, E.
(2008). Association Between ADAMTS1 Matrix Metalloproteinase Gene Variation, Coronary Heart Disease, and Benefit of Statin Therapy. Arterioscler. Thromb. Vasc. Bio.
28: 562-567
[Abstract][Full Text]
Vergouwen, M. D.I., de Haan, R. J., Vermeulen, M., Roos, Y. B.W.E.M.
(2008). Statin Treatment and the Occurrence of Hemorrhagic Stroke in Patients With a History of Cerebrovascular Disease. Stroke
39: 497-502
[Abstract][Full Text]
Wienbergen, H., Senges, J., Gitt, A. K.
(2008). Should We Prescribe Statin and Aspirin for Every Diabetic Patient?: Is it time for a polypill?. Diabetes Care
31: S222-S225
[Full Text]
Iakoubova, O. A., Tong, C. H., Rowland, C. M., Kirchgessner, T. G., Young, B. A., Arellano, A. R., Shiffman, D., Sabatine, M. S., Campos, H., Packard, C. J., Pfeffer, M. A., White, T. J., Braunwald, E., Shepherd, J., Devlin, J. J., Sacks, F. M.
(2008). Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials.. J Am Coll Cardiol
51: 435-443
[Abstract][Full Text]
Shiffman, D., Chasman, D. I., Zee, R. Y.L., Iakoubova, O. A., Louie, J. Z., Devlin, J. J., Ridker, P. M.
(2008). A kinesin family member 6 variant is associated with coronary heart disease in the Women's Health Study.. J Am Coll Cardiol
51: 444-448
[Abstract][Full Text]
Superko, H. R., King, S. III
(2008). Lipid Management to Reduce Cardiovascular Risk: A New Strategy Is Required. Circulation
117: 560-568
[Full Text]
Mizuno, K., Nakaya, N., Ohashi, Y., Tajima, N., Kushiro, T., Teramoto, T., Uchiyama, S., Nakamura, H., for the MEGA Study Group,
(2008). Usefulness of Pravastatin in Primary Prevention of Cardiovascular Events in Women: Analysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA Study). Circulation
117: 494-502
[Abstract][Full Text]
Tonelli, M., Sacks, F., Arnold, M., Moye, L., Davis, B., Pfeffer, M., for the Cholesterol and Recurrent Events (CARE) Tr,
(2008). Relation Between Red Blood Cell Distribution Width and Cardiovascular Event Rate in People With Coronary Disease. Circulation
117: 163-168
[Abstract][Full Text]
Yagi, S., Aihara, K.-i., Ikeda, Y., Sumitomo, Y., Yoshida, S., Ise, T., Iwase, T., Ishikawa, K., Azuma, H., Akaike, M., Matsumoto, T.
(2008). Pitavastatin, an HMG-CoA Reductase Inhibitor, Exerts eNOS-Independent Protective Actions Against Angiotensin II Induced Cardiovascular Remodeling and Renal Insufficiency. Circ. Res.
102: 68-76
[Abstract][Full Text]
Afilalo, J., Duque, G., Steele, R., Jukema, J. W., de Craen, A. J.M., Eisenberg, M. J.
(2008). Statins for secondary prevention in elderly patients: a hierarchical bayesian meta-analysis.. J Am Coll Cardiol
51: 37-45
[Abstract][Full Text]
Brown, M. L., Sundt, T. M. III, Gersh, B. J.
(2008). Indications for Revascularization. Card Surg Adult
3: 551-572
[Full Text]
Natarajan, N., Putnam, R. W., Yip, A. M., Frail, D.
(2007). Family practice patients' adherence to statin medications. cfp
53: 2144-2145
[Abstract][Full Text]
Rosengarten, B., Auch, D., Kaps, M.
(2007). Effects of Initiation and Acute Withdrawal of Statins on the Neurovascular Coupling Mechanism in Healthy, Normocholesterolemic Humans. Stroke
38: 3193-3197
[Abstract][Full Text]
Shimamura, M., Sato, N., Sata, M., Kurinami, H., Takeuchi, D., Wakayama, K., Hayashi, T., Iida, H., Morishita, R.
(2007). Delayed Postischemic Treatment With Fluvastatin Improved Cognitive Impairment After Stroke in Rats. Stroke
38: 3251-3258
[Abstract][Full Text]
Kjekshus, J., Apetrei, E., Barrios, V., Bohm, M., Cleland, J. G.F., Cornel, J. H., Dunselman, P., Fonseca, C., Goudev, A., Grande, P., Gullestad, L., Hjalmarson, A., Hradec, J., Janosi, A., Kamensky, G., Komajda, M., Korewicki, J., Kuusi, T., Mach, F., Mareev, V., McMurray, J. J.V., Ranjith, N., Schaufelberger, M., Vanhaecke, J., van Veldhuisen, D. J., Waagstein, F., Wedel, H., Wikstrand, J., the CORONA Group,
(2007). Rosuvastatin in Older Patients with Systolic Heart Failure. NEJM
357: 2248-2261
[Abstract][Full Text]
Grover, S. A., Lowensteyn, I., Joseph, L., Kaouache, M., Marchand, S., Coupal, L., Boudreau, G., for the Cardiovascular Health Evaluation to Improv,
(2007). Patient Knowledge of Coronary Risk Profile Improves the Effectiveness of Dyslipidemia Therapy: The CHECK-UP Study: A Randomized Controlled Trial. Arch Intern Med
167: 2296-2303
[Abstract][Full Text]
Wang, R., Lagakos, S. W., Ware, J. H., Hunter, D. J., Drazen, J. M.
(2007). Statistics in Medicine -- Reporting of Subgroup Analyses in Clinical Trials. NEJM
357: 2189-2194
[Full Text]
Arsenault, B. J., Lemieux, I., Despres, J.-P., Wareham, N. J., Luben, R., Kastelein, J. J.P., Khaw, K.-T., Boekholdt, S. M.
(2007). Cholesterol levels in small LDL particles predict the risk of coronary heart disease in the EPIC-Norfolk prospective population study. Eur Heart J
28: 2770-2777
[Abstract][Full Text]
Flick, E. D., Habel, L. A., Chan, K. A., Van Den Eeden, S. K., Quinn, V. P., Haque, R., Orav, E. J., Seeger, J. D., Sadler, M. C., Quesenberry, C. P. Jr., Sternfeld, B., Jacobsen, S. J., Whitmer, R. A., Caan, B. J.
(2007). Statin Use and Risk of Prostate Cancer in the California Men's Health Study Cohort. Cancer Epidemiol. Biomarkers Prev.
16: 2218-2225
[Abstract][Full Text]
Agarwal, R.
(2007). Effects of Statins on Renal Function. Mayo Clin Proc.
82: 1381-1390
[Abstract][Full Text]
Feringa, H. H.H., Schouten, O., Karagiannis, S. E., Brugts, J., Elhendy, A., Boersma, E., Vidakovic, R., van Sambeek, M. R.H.M., Noordzij, P. G., Bax, J. J., Poldermans, D.
(2007). Intensity of Statin Therapy in Relation to Myocardial Ischemia, Troponin T Release, and Clinical Cardiac Outcome in Patients Undergoing Major Vascular Surgery. J Am Coll Cardiol
50: 1649-1656
[Abstract][Full Text]
Ford, I., Murray, H., Packard, C. J., Shepherd, J., Macfarlane, P. W., Cobbe, S. M., the West of Scotland Coronary Prevention Study Gro,
(2007). Long-Term Follow-up of the West of Scotland Coronary Prevention Study. NEJM
357: 1477-1486
[Abstract][Full Text]
Cortigiani, L., Rigo, F., Gherardi, S., Sicari, R., Galderisi, M., Bovenzi, F., Picano, E.
(2007). Additional Prognostic Value of Coronary Flow Reserve in Diabetic and Nondiabetic Patients With Negative Dipyridamole Stress Echocardiography by Wall Motion Criteria. J Am Coll Cardiol
50: 1354-1361
[Abstract][Full Text]
Gortney, J. S., Sanders, R. M.
(2007). Impact of C-reactive protein on treatment of patients with cardiovascular disease. Am J Health Syst Pharm
64: 2009-2016
[Abstract][Full Text]
Gnavi, R., Migliardi, A., Demaria, M., Petrelli, A., Caprioglio, A., Costa, G.
(2007). Statins prescribing for the secondary prevention of ischaemic heart disease in Torino, Italy. A case of ageism and social inequalities. Eur J Public Health
17: 492-496
[Abstract][Full Text]
Cortigiani, L., Sicari, R., Desideri, A., Bigi, R., Bovenzi, F., Picano, E., on behalf of the VIDA (Viability Identification wi,
(2007). Dobutamine stress echocardiography and the effect of revascularization on outcome in diabetic and non-diabetic patients with chronic ischaemic left ventricular dysfunction. Eur J Heart Fail
9: 1038-1043
[Abstract][Full Text]
Cahoon, W. D Jr, Crouch, M. A
(2007). Preprocedural Statin Therapy in Percutaneous Coronary Intervention. The Annals of Pharmacotherapy
41: 1687-1693
[Abstract][Full Text]
Barter, P., Gotto, A. M., LaRosa, J. C., Maroni, J., Szarek, M., Grundy, S. M., Kastelein, J. J.P., Bittner, V., Fruchart, J.-C., the Treating to New Targets Investigators,
(2007). HDL Cholesterol, Very Low Levels of LDL Cholesterol, and Cardiovascular Events. NEJM
357: 1301-1310
[Abstract][Full Text]
Lipson, A. H., Fallis, W. M., Wang, X., Yi, Y.
(2007). Are patients with hyperlipidemia undertreated?: Study of patients admitted to hospital with coronary events. cfp
53: 1502-1507
[Abstract][Full Text]
Perler, B. A.
(2007). Should Statins Be Given Routinely Before Carotid Endarterectomy?. PERSPECT VASC SURG ENDOVASC THER
19: 240-245
[Abstract]
Anderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E. Jr, Chavey, W. E. II, Fesmire, F. M., Hochman, J. S., Levin, T. N., Lincoff, A. M., Peterson, E. D., Theroux, P., Wenger, N. K., Wright, R. S., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Halperin, J. L., Hunt, S. A., Krumholz, H. M., Kushner, F. G., Lytle, B. W., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B.
(2007). ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol
50: e1-e157
[Full Text]
Anderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E. Jr, Chavey, W. E. II, Fesmire, F. M., Hochman, J. S., Levin, T. N., Lincoff, A. M., Peterson, E. D., Theroux, P., Wenger, N. K., Wright, R. S., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Halperin, J. L., Hunt, S. A., Krumholz, H. M., Kushner, F. G., Lytle, B. W., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B.
(2007). ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol
50: 652-726
[Full Text]
Bonovas, S., Filioussi, K., Flordellis, C. S., Sitaras, N. M.
(2007). Statins and the Risk of Colorectal Cancer: A Meta-Analysis of 18 Studies Involving More Than 1.5 Million Patients. JCO
25: 3462-3468
[Abstract][Full Text]
